Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MerTK as a therapeutic target in glioblastoma
Jing Wu, Lauren N. Frady, Ryan Bash, et al.
Neuro-Oncology (2017) Vol. 20, Iss. 1, pp. 92-102
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
Christina Morse, Tracy Tabib, John Sembrat, et al.
European Respiratory Journal (2019) Vol. 54, Iss. 2, pp. 1802441-1802441
Open Access | Times Cited: 591
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
K. Myers, Sarah R. Amend, Kenneth J. Pienta
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 334
Glial and myeloid heterogeneity in the brain tumour microenvironment
Brian M. Andersen, Camilo Faust Akl, Michael A. Wheeler, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 12, pp. 786-802
Open Access | Times Cited: 144
Tumor-Associated Macrophage Status in Cancer Treatment
Anna Maria Malfitano, Simona Pisanti, Fabiana Napolitano, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1987-1987
Open Access | Times Cited: 139
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 69
Bacterial outer membrane vesicle based versatile nanosystem boosts the efferocytosis blockade triggered tumor-specific immunity
Wanru Zhuang, Yunfeng Wang, Weidong Nie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 57
Macrophages in Recurrent Glioblastoma as a Prognostic Factor in the Synergistic System of the Tumor Microenvironment
Nicola Montemurro, Bhavya Pahwa, Anish Tayal, et al.
Neurology International (2023) Vol. 15, Iss. 2, pp. 595-608
Open Access | Times Cited: 42
Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention
Xuefei Zhou, Xiangrui Liu, Leaf Huang
Advanced Functional Materials (2020) Vol. 31, Iss. 5
Open Access | Times Cited: 114
KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway
Wenwen Du, Jianjie Zhu, Yuanyuan Zeng, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 4, pp. 1284-1300
Open Access | Times Cited: 103
Targeting tumour microenvironment by tyrosine kinase inhibitor
Hor‐Yue Tan, Ning Wang, Wing Lam, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 98
Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor
Yumi Yokoyama, Erin D. Lew, Ruth Seelige, et al.
Cancer Research (2019) Vol. 79, Iss. 8, pp. 1996-2008
Open Access | Times Cited: 76
Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma
Hélène Grégoire, Loris Roncali, Audrey Rousseau, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 71
MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
Justus M. Huelse, Diana Fridlyand, Shelton Earp, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107577-107577
Open Access | Times Cited: 71
Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?
Ni Tong, Zhenqiang He, Yujie Ma, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 62
Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming
Ting Zhao, Jianming Zeng, Yujie Xu, et al.
Theranostics (2022) Vol. 12, Iss. 16, pp. 6989-7008
Open Access | Times Cited: 47
The roles of tissue resident macrophages in health and cancer
Minmin Cao, Zihao Wang, Wanying Lan, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment
Davide Frumento, Giancarlo Grossi, Marta Falesiedi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1398-1398
Open Access | Times Cited: 10
Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
Jun Ma, Clark C. Chen, Ming Li
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5775-5775
Open Access | Times Cited: 47
Tissue-specific modifier alleles determine Mertk loss-of-function traits
Yemsratch T. Akalu, María E. Mercau, Marleen Ansems, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 35
Efferocytosis Nanoinhibitors to Promote Secondary Necrosis and Potentiate the Immunogenicity of Conventional Cancer Therapies for Improved Therapeutic Benefits
Yumin Wu, Chunjie Wang, Yifan Yan, et al.
ACS Nano (2023) Vol. 17, Iss. 18, pp. 18089-18102
Closed Access | Times Cited: 17
Tumour-associated macrophages heterogeneity drives resistance to clinical therapy
Shuangshuang Guo, Xiaojing Chen, Chu-Hong Guo, et al.
Expert Reviews in Molecular Medicine (2022) Vol. 24
Open Access | Times Cited: 26
The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma
Lingyun Zhang, Yu Jiang, Gao Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Decoding glioblastoma’s diversity: are neurons part of the game?
Marta Maleszewska, Adria‐Jaume Roura, Michał J. Dąbrowski, et al.
Cancer Letters (2025), pp. 217666-217666
Open Access
Efferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?
Danfeng Lin, Xiaodiao Kang, Lu Shen, et al.
Molecular Therapy — Oncolytics (2020) Vol. 17, pp. 394-407
Open Access | Times Cited: 31
Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages
Mariana Reis-Sobreiro, Afonso Teixeira da Mota, Carolina Jardim, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2364-2364
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top